文献速递心血管MR

青少年接种COVID-19 mRNA疫苗后心肌炎的心脏MRI表现

Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
PubMed 文献 · AJR Am J Roentgenol · 2021-10-27

本研究回顾性分析了2021年5月14日至6月14日期间5例无既往SARS-CoV-2感染、在接种第二剂COVID-19 mRNA疫苗后4天内出现疑似心肌炎的男性青少年(16-19岁,平均17.2±1.0岁)的心脏MRI表现。所有患者肌钙蛋白I升高(平均峰值6.82±4.13 ng/mL),心脏MRI均符合Lake Louise心肌炎标准,表现为早期钆增强和晚期钆增强(LGE),4例伴心肌水肿。所有患者住院经过顺利(平均住院4.8天),出院后3例有轻微间歇性自限性胸痛,2例无复发症状;2例复查MRI显示LGE持续但减轻。作者指出这些观察不能确立因果关系,放射科医生应意识到COVID-19 mRNA疫苗接种与心肌炎之间可能的相关性。

要点

  • 青少年男性接种第二剂COVID-19 mRNA疫苗后4天内出现疑似心肌炎时,心脏MRI可显示典型心肌炎征象。
  • 所有5例患者均符合Lake Louise标准,表现为早期钆增强和LGE,4例伴心肌水肿。
  • 2例复查MRI显示LGE持续但减轻,提示影像随访可能有助于评估转归。

核心结论

  • 在这个小型病例系列中,接种COVID-19疫苗后心肌炎患者均为男性青少年,初始临床经过良好;所有患者心脏MRI表现与其他原因心肌炎相似,2例复查MRI显示LGE持续;这些观察不能确立因果关系。

研究设计与样本

  • 回顾性研究,纳入2021年5月14日至6月14日期间因接种COVID-19 mRNA疫苗后2周内疑似心肌炎而接受心脏MRI的无已知既往SARS-CoV-2感染患者5例,由一名心胸影像 fellow 和一名心胸放射科医生共识阅片,数据描述性总结。

关键影像表现/征象

  • 所有5例患者均可见早期钆增强和晚期钆增强(LGE),4例伴相应心肌水肿;2例复查心脏MRI显示LGE持续但减轻。

诊断标准与关键数值

  • 基于Lake Louise标准,5例患者心脏MRI表现均符合心肌炎;所有患者肌钙蛋白升高,平均峰值肌钙蛋白I为6.82±4.13 ng/mL。

临床应用与阅片要点

  • 放射科医生应意识到COVID-19 mRNA疫苗接种与心肌炎之间可能存在关联,并认识心脏MRI在评估接种后疑似心肌炎中的作用。

局限性

  • 小型病例系列;这些观察不能确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. A possible association has been reported between COVID-19 messenger RNA (mRNA) vaccination and myocarditis. OBJECTIVE. The purpose of our study was to describe cardiac MRI findings in patients with myocarditis after COVID-19 mRNA vaccination. METHODS. This retrospective study included patients without known prior SARS-CoV-2 infection who underwent cardiac MRI between May 14, 2021, and June 14, 2021, for suspected myocarditis within 2 weeks of COVID-19 mRNA vaccination. Information regarding clinical presentation, hospital course, and events after hospital discharge were recorded. A cardiothoracic imaging fellow and cardiothoracic radiologist reviewed cardiac MRI examinations in consensus. Data were summarized descriptively. RESULTS. Of 52 patients without known prior SARS-CoV-2 infection who underwent cardiac MRI during the study period, five underwent MRI for suspected myocarditis after recent COVID-19 mRNA vaccination. All five patients were male patients ranging in age from 16 to 19 years (mean, 17.2 ± 1.0 [SD] years) who presented within 4 days of receiving the second dose of a COVID-19 mRNA vaccine. Troponin levels were elevated in all patients (mean peak troponin I value, 6.82 ± 4.13 ng/mL). Alternate possible causes of myocarditis were deemed clinically unlikely on the basis of medical history, physical examination findings, myocarditis viral panel, and toxicology screening. Cardiac MRI findings were consistent with myocarditis in all five patients on the basis of the Lake Louise criteria, including early gadolinium enhancement and late gadolinium enhancement (LGE) in all patients and corresponding myocardial edema in four patients. All five patients had a favorable hospital course and were discharged from the hospital in stable condition with improved or resolved symptoms after hospitalization (mean length of hospital stay, 4.8 days). Two patients underwent repeat cardiac MRI that showed persistent, although decreased, LGE. Three patients reported mild intermittent self-resolving chest pain after hospital discharge, and two patients had no recurrent symptoms after discharge. CONCLUSION. In this small case series, all patients with myocarditis after COVID-19 vaccination were male adolescents and had a favorable initial clinical course. All patients showed cardiac MRI findings typical of myocarditis from other causes. LGE persisted in two patients who underwent repeat MRI. These observations do not establish causality. CLINICAL IMPACT. Radiologists should be aware of a possible association of COVID-19 mRNA vaccination and myocarditis and recognize the role of cardiac MRI in the assessment of suspected myocarditis after COVID-19 vaccination.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Chelala L, Jeudy J, Hossain R, et al. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. 2021. PMID: 34704459. doi:10.2214/AJR.21.26853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。